National Quality Measures Clearinghouse | 'atrial fibrillation'

National Quality Measures Clearinghouse | Search Results

1-20 of 21   Next >
1.   Atrial fibrillation: the practice can produce a register of patients with atrial fibrillation. 2009 Mar. [NQMC Update Pending] NQMC:005116 British Medical Association - Medical Specialty Society; National Health Service (NHS) Confederation - National Government Agency [Non-U.S.]. View all measures by the developer(s) Compare Selected
2.   Cardiovascular disease: percentage of patients discharged with a diagnosis of congestive heart failure (CHF) and atrial fibrillation (AF) who have no contraindication to the use of warfarin, who are prescribed warfarin, during the 6 month time period. 2011 Jan. [NQMC Update Pending] NQMC:006655 Australian Council on Healthcare Standards - Health Care Accreditation Organization. View all measures by the developer(s) Compare Selected
3.   Stroke and stroke rehabilitation: percentage of patients aged 18 years and older with the diagnosis of ischemic stroke or TIA with documented permanent, persistent, or paroxysmal atrial fibrillation who were prescribed an anticoagulant at discharge. 2010 Sep. NQMC:002907 American Academy of Neurology - Medical Specialty Society; American College of Radiology - Medical Specialty Society; National Committee for Quality Assurance - Health Care Accreditation Organization; Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected
4.   Stroke: percent of ischemic stroke patients with atrial fibrillation/flutter who are prescribed anticoagulation therapy at hospital discharge. 2010 Apr. [NQMC Update Pending] NQMC:006107 The Joint Commission - Health Care Accreditation Organization. View all measures by the developer(s) Compare Selected
5.   Atrial fibrillation (AF) and atrial flutter: percentage of calendar months during the reporting year during which patients aged 18 years and older with a diagnosis of nonvalvular AF or atrial flutter, receiving warfarin therapy, have at least one INR measurement made. 2007 Dec. NQMC:004005 American College of Cardiology Foundation - Medical Specialty Society; American Heart Association - Medical Specialty Society; Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected
6.   Atrial fibrillation (AF) and atrial flutter: percentage of patients aged 18 years and older with a diagnosis of nonvalvular AF or atrial flutter at high risk for thromboembolism who were prescribed warfarin during the 12 month reporting period. 2007 Dec. NQMC:004004 American College of Cardiology Foundation - Medical Specialty Society; American Heart Association - Medical Specialty Society; Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected
7.   Atrial fibrillation (AF) and atrial flutter: percentage of patients aged 18 years and older with a diagnosis of nonvalvular AF or atrial flutter with an assessment of all of the specified thromboembolic risk factors documented. 2007 Dec. NQMC:004003 American College of Cardiology Foundation - Medical Specialty Society; American Heart Association - Medical Specialty Society; Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected
8.   Coronary heart disease: percentage of patients with a history of myocardial infarction currently treated with an ACE inhibitor (or ARB if ACE intolerant), aspirin or an alternative anti-platelet therapy, beta-blocker and statin. 2012 Mar. NQMC:006921 British Medical Association - Medical Specialty Society; National Health Service (NHS) Confederation - National Government Agency [Non-U.S.]. View all measures by the developer(s) Compare Selected
9.   Stroke: percent of ischemic stroke patients prescribed antithrombotic therapy at hospital discharge. 2010 Apr. [NQMC Update Pending] NQMC:006106 The Joint Commission - Health Care Accreditation Organization. View all measures by the developer(s) Compare Selected
10.   Stroke and transient ischaemic attack (TIA): the percentage of patients with a stroke shown to be non-haemorrhagic, or a history of TIA, who have a record that an anti-platelet agent (aspirin, clopidogrel, dipyridamole or a combination), or anti-coagulant is being taken (unless a contraindication or side-effects are recorded). 2009 Mar. [NQMC Update Pending] NQMC:005059 British Medical Association - Medical Specialty Society; National Health Service (NHS) Confederation - National Government Agency [Non-U.S.]. View all measures by the developer(s) Compare Selected
11.   Percent time in therapeutic INR range (TTR): mean TTR achieved among patients who received prescriptions for warfarin and had sufficient INR values to calculate TTR. 2011 Jan. NQMC:006321 Rose, Adam, MD, MSc, FACP; Berlowitz, Dan, MD, MPH; Reisman, Joel, AB; Ash, Arlene, PhD; Ozonoff, Al, PhD; Hylek, Elaine, MD, MPH - Independent Author(s); U.S. Department of Veterans Affairs, Health Services Research and Development Service, Center for Health Quality, Outcomes and Economic Research (CHQOER) - Government Affiliated Research Institute. View all measures by the developer(s) Compare Selected
12.   Pay for Performance in UK General Practice – The Ambiguous Impact of the Quality and Outcomes Framework Compare Selected
13.   Heart failure: percentage of patient visits for those patients aged 18 years and older with a diagnosis of heart failure and with quantitative results of an evaluation of both level of activity AND clinical symptoms documented in which patient symptoms have improved or remained consistent with treatment goals since last assessment OR patient symptoms have demonstrated clinically important deterioration since last assessment with a documented plan of care. 2011 Jan. NQMC:007228 American College of Cardiology Foundation - Medical Specialty Society; American Heart Association - Medical Specialty Society; Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected
14.   Heart failure: percentage of patient visits for those patients aged 18 years and older with a diagnosis of heart failure with quantitative results of an evaluation of both current level of activity and clinical symptoms documented. 2011 Jan. NQMC:007227 American College of Cardiology Foundation - Medical Specialty Society; American Heart Association - Medical Specialty Society; Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected
15.   Heart failure: percentage of patients aged 18 years and older with a diagnosis of heart failure for whom the quantitative or qualitative results of a recent or prior (any time in the past) LVEF assessment is documented within a 12 month period. 2011 Jan. NQMC:007225 American College of Cardiology Foundation - Medical Specialty Society; American Heart Association - Medical Specialty Society; Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected
16.   Heart failure: percentage of patients aged 18 years and older with a diagnosis of heart failure who were provided with self-care education on three or more elements of education during one or more visits within a 12 month period. 2011 Jan. NQMC:007229 American College of Cardiology Foundation - Medical Specialty Society; American Heart Association - Medical Specialty Society; Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected
17.   Heart failure: percentage of patients aged 18 years and older with a diagnosis of heart failure with a current or prior left LVEF less than 40% who were prescribed ACE inhibitor or ARB therapy either within a 12 month period when seen in the outpatient setting or at hospital discharge. 2011 Jan. NQMC:007231 American College of Cardiology Foundation - Medical Specialty Society; American Heart Association - Medical Specialty Society; Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected
18.   Heart failure: percentage of patients aged 18 years and older with a diagnosis of heart failure with a current or prior LVEF less than 40% who were prescribed beta-blocker therapy either within a 12 month period when seen in the outpatient setting or at hospital discharge. 2011 Jan. NQMC:007230 American College of Cardiology Foundation - Medical Specialty Society; American Heart Association - Medical Specialty Society; Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected
19.   Heart failure: percentage of patients aged 18 years and older with a diagnosis of heart failure with current LVEF less than or equal to 35% despite ACE inhibitor/ARB and beta-blocker therapy for at least three months who were counseled regarding implantable cardioverter-defibrillator (ICD) implantation as a treatment option for the prophylaxis of sudden death. 2011 Jan. NQMC:007232 American College of Cardiology Foundation - Medical Specialty Society; American Heart Association - Medical Specialty Society; Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected
20.   Heart failure: percentage of patients aged 18 years and older with a principal discharge diagnosis of heart failure with documentation in the hospital record of the results of a LVEF assessment that was performed either before arrival or during hospitalization, OR documentation in the hospital record that LVEF assessment is planned for after discharge. 2011 Jan. NQMC:007226 American College of Cardiology Foundation - Medical Specialty Society; American Heart Association - Medical Specialty Society; Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration. View all measures by the developer(s) Compare Selected
1-20 of 21   Next >